Mixed Prospects for Vaccinating Children October 29, 2021 Perspective In this Axios column, Drew Altman examines the data about what parents say they will do once their children ages 5-11 become eligible for a COVID-19 vaccine, and why it will take some time and a concerted outreach effort to match adult vaccination rates.
The Inequity Of The Medicaid Coverage Gap and Why It Is Hard To Fix It October 14, 2021 Perspective In this column for the JAMA Health Forum, Larry Levitt explores why the Medicaid “coverage gap” still exists in 12 states that have not expanded their Medicaid programs under the Affordable Care Act, why it matters, and why eliminating it could prove challenging.
A Look at Who is Still Not Vaccinated Against COVID October 7, 2021 Perspective In this Axios column, Drew Altman takes on the idea that communities of color are behind the problem of the unvaccinated in the U.S.
Why The California Recall Is Not a Harbinger of What Is to Come on COVID As a Campaign Issue September 28, 2021 Perspective In this Axios column, Drew Altman examines the lessons for COVID-19 as a political issue from Governor Gavin Newsom’s resounding win in California’s recall election.
Parents Report More Negative Pandemic Effects on Kids Who Attend School Virtually vs. In-Person August 20, 2021 Perspective In his latest Axios column, Drew Altman shows that parents feel that children have fared better during COVID attending school in-person than virtually in terms of academic performance and their mental health and wellbeing.
How Full FDA Approval Could Spur Vaccination August 13, 2021 Perspective In this Axios column, Drew Altman says full FDA approval of COVID-19 vaccines can provide a big boost to vaccination efforts if treated as an opportunity for updated messaging from government officials at all levels and public health experts and new actions from employers.
The Health System Appears To Be Selling LGBT+ People Short August 2, 2021 Perspective With much focus on equity in the nation’s health care system during the pandemic, Drew Altman’s Axios column brings attention to warning signs about health care provided to LGBT+ individuals.
The Sleeper Health Cost Policy July 22, 2021 Perspective In this Axios column, Drew Altman unpacks President Biden’s recent executive order on promoting competition, exploring its significance for new efforts to control health costs by addressing consolidation in the health care industry.
Why Drug Price Negotiation Has Staying Power June 25, 2021 Perspective In this Axios column, Drew Altman looks beyond Medicare to what’s at stake for employers and workers in the debate about the government negotiating drug prices.
Expanding Medicare to Adults at Age 60 Years—Medicare-for-More? May 27, 2021 Perspective In this column for the JAMA Health Forum, Larry Levitt examines the implications of lowering Medicare’s age of eligibility, which is emerging as a potential pathway toward Medicare-for-all or a public option among single-payer advocates. He explores the implications for costs, industry, people and broader reform efforts.
